Cargando…

5-FU-miR-15a Inhibits Activation of Pancreatic Stellate Cells by Reducing YAP1 and BCL-2 Levels In Vitro

Chronic pancreatitis is characterized by chronic inflammation and fibrosis, processes heightened by activated pancreatic stellate cells (PSCs). Recent publications have demonstrated that miR-15a, which targets YAP1 and BCL-2, is significantly downregulated in patients with chronic pancreatitis compa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almanzar, Vanessa M. Diaz, Shah, Kunal, LaComb, Joseph F., Mojumdar, Aisharja, Patel, Hetvi R., Cheung, Jacky, Tang, Meiyi, Ju, Jingfang, Bialkowska, Agnieszka B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961454/ https://www.ncbi.nlm.nih.gov/pubmed/36835366 http://dx.doi.org/10.3390/ijms24043954

Ejemplares similares

The Role of MicroRNAs in Pancreatitis Development and Progression
por: Patel, Hetvi R., et al.
Publicado: (2023)

SP and KLF Transcription Factors in Cancer Metabolism
por: Orzechowska-Licari, Emilia J., et al.
Publicado: (2022)

The Role of Krüppel-like Factors in Pancreatic Physiology and Pathophysiology
por: Giarrizzo, Michael, et al.
Publicado: (2023)

AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor
por: Ingle, Komala, et al.
Publicado: (2023)

Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake
por: Fesler, Andrew, et al.
Publicado: (2022)

Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1
por: Fesler, Andrew, et al.
Publicado: (2017)

Combinational inhibition of EGFR and YAP reverses 5-Fu resistance in colorectal cancer
por: Huang, Changhao, et al.
Publicado: (2020)

C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC
por: Chen, Xiyan, et al.
Publicado: (2017)

miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells
por: Meng, Xiaomin, et al.
Publicado: (2018)

Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis
por: Morvaridi, Susan, et al.
Publicado: (2015)

Krüppel-like Factors 4 and 5 in Colorectal Tumorigenesis
por: Lee, Esther, et al.
Publicado: (2023)

Modulation of Bcl-x Alternative Splicing Induces Apoptosis of Human Hepatic Stellate Cells
por: Wu, Lin, et al.
Publicado: (2016)

Alterations of the extracellular matrix in ovarian cancer studied by Second Harmonic Generation imaging microscopy
por: Nadiarnykh, Oleg, et al.
Publicado: (2010)

Diallyl trisulfide plays an antifibrotic role by inhibiting the expression of Bcl‐2 in hepatic stellate cells
por: Pang, Huai, et al.
Publicado: (2022)

PNPLA3 I148M Up-Regulates Hedgehog and Yap Signaling in Human Hepatic Stellate Cells
por: Bruschi, Francesca Virginia, et al.
Publicado: (2020)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

YAP inhibits autophagy and promotes progression of colorectal cancer via upregulating Bcl-2 expression
por: Jin, Lan, et al.
Publicado: (2021)

Halofuginone inhibits tumorigenic progression of 5-FU-resistant human colorectal cancer HCT-15/FU cells by targeting miR-132-3p in vitro
por: Wang, Chen, et al.
Publicado: (2020)

Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU
por: Li, Xin, et al.
Publicado: (2015)

ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation
por: Zhang, Kun, et al.
Publicado: (2016)

12-O-tetradecanoylphorbol-13-acetate Reduces Activation of Hepatic Stellate Cells by Inhibiting the Hippo Pathway Transcriptional Coactivator YAP
por: Kim, Chang Wan, et al.
Publicado: (2022)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

Aberrant DNA Methylation: Implications in Racial Health Disparity
por: Wang, Xuefeng, et al.
Publicado: (2016)

Correction: Aberrant DNA Methylation: Implications in Racial Health Disparity
por: Wang, Xuefeng, et al.
Publicado: (2016)

The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis
por: Ding, Qian, et al.
Publicado: (2019)

Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer
por: Hwang, Ga-Ram, et al.
Publicado: (2023)

PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
por: Conley-LaComb, M Katie, et al.
Publicado: (2013)

Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019)

Nrf3 Promotes 5-FU Resistance in Colorectal Cancer Cells via the NF-κB/BCL-2 Signaling Pathway In Vitro and In Vivo
por: Cai, Bi-Qing, et al.
Publicado: (2021)

RASSF4 inhibits cell proliferation and increases drug sensitivity in colorectal cancer through YAP/Bcl‐2 pathway
por: Han, Yong, et al.
Publicado: (2022)

Gastroesophageal reflux and PPI exposure alter gut microbiota in very young infants
por: Francis, Denease, et al.
Publicado: (2023)

5-FU toxicity and nutritional deficiencies.
por: Stenram, U.
Publicado: (1993)

FuSuMaTech workshop
por: Olofsson, Simon
Publicado: (2018)

Fluorouracil (5-FU)-induced Cardiomyopathy
por: Thalambedu, Nishanth, et al.
Publicado: (2019)

Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions
por: Yang, Jing, et al.
Publicado: (2023)

RETROSPECTIVE CASE SERIES OF 15 PATIENTS TREATED WITH CHEMORADIATION USING 5-FU AND NEDAPLATIN FOR GYNECOLOGICAL MALIGNANCY: WITH REGARD TO HEMOTOXICITY
por: ITOH, YOSHIYUKI, et al.
Publicado: (2014)

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure
por: Dolat, Marine, et al.
Publicado: (2020)

Targeting 15d-Prostaglandin J(2) to Hepatic Stellate Cells: Two Options Evaluated
por: Hagens, Werner I., et al.
Publicado: (2007)

The FU gene and its possible protein isoforms
por: Østerlund, Torben, et al.
Publicado: (2004)

George Fu Gao: the past and future of Ebola
por: Poo, Mu-ming, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h55gmacu05mv79k76kqane5jpp